This week we look at NurOwn® for multiple sclerosis, a combination therapy failing to meet primary endpoint for glioblastoma and warnings from the US FDA.
New studies in which animal models have been utilized to study opioid addiction, withdrawal and relapse may offer insights into managing the opioid epidemic in humans.
Three studies have been highlighted at SfN Neuroscience on the links between adolescent brain development, mental health and substance abuse.
Two clinical trials of a combined therapy targeting the opioid system have suggested significant symptom reduction in people with major depression.
In the largest exome sequencing of autism spectrum disorder to date, researchers have identified 102 possible gene candidates.
Following the publication of the James Lind Alliance Priority Setting Partnership ‘Digital Technology for Mental Health’ top ten research priorities, this article, from the UK, considers the challenge of creating a truly user-driven approach to realize the promise of digital mental health.
A novel study has revealed that elevated pesticide levels in pregnant women are associated with an increased risk of autism among their children.
In this interview, Matthew Hill speaks to us about how endocannabinoids could be a mechanism of comorbidity between inflammatory disease and anxiety.
In the largest study of its kind, researchers have revealed that individuals who exercise report having fewer days of poor mental health than those who do not exercise.
Researchers have demonstrated that a pregnant mother’s gut health may be linked to the risk of autism development in their offspring; this may lead to a new understanding of how to prevent neurodevelopmental disorders.